Ilya Pharma AB

Ilya Pharma AB develops biopharmaceutical immunotherapies. The Company focuses on creating local-acting treatments using genetically modified lactic acid bacteria, conducting clinical research for wound healing, colitis, and multi- drug resistant infections. Ilya Pharma AB serves patients with difficult-to-heal wounds, rare diseases, and colitis in Sweden, Europe, and the United States.